These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17953921)

  • 1. [Prognostic value of ECG in diabetes mellitus: the danger of "knowing too much"].
    Rodríguez-Padial L
    Rev Esp Cardiol; 2007 Oct; 60(10):1015-7. PubMed ID: 17953921
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular risks in type 2 diabetes and secondary cardiovascular prevention.
    Ducimetière P
    Diabetes Metab; 2005 Nov; 31(5):503-6. PubMed ID: 16357796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Type 2 diabetes mellitus and coronary heart disease].
    Brändle M; Amann FW; Salomon F
    Schweiz Med Wochenschr; 1999 May; 129(18):700-6. PubMed ID: 10407943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay of diabetes and coronary heart disease on cardiovascular mortality.
    Boccara F; Cohen A
    Heart; 2004 Dec; 90(12):1371-3. PubMed ID: 15547003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic value of ECGs in patients with type-2 diabetes mellitus without known cardiovascular disease].
    de Santiago A; García-Lledó A; Ramos E; Santiago C
    Rev Esp Cardiol; 2007 Oct; 60(10):1035-41. PubMed ID: 17953924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose control in type 2 diabetes: still worthwhile and worth pursuing.
    Kahn SE
    JAMA; 2009 Apr; 301(15):1590-2. PubMed ID: 19366780
    [No Abstract]   [Full Text] [Related]  

  • 7. When a quick sound bite won't do.
    Mandell BF
    Cleve Clin J Med; 2008 Oct; 75(10):686. PubMed ID: 18939383
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular event prevention in the person with type 2 diabetes: case examples for identifying and treating multiple risks.
    Balasubramanyam A; Hinnen D; Polonsky W
    Diabetes Educ; 2006; 32 Suppl 5():163S-173S; quiz 174S-177S. PubMed ID: 16873585
    [No Abstract]   [Full Text] [Related]  

  • 9. Duration of diabetes, glucose control and cardiovascular risk.
    Emanuele NV
    Diabetologia; 2010 Jan; 53(1):214-5. PubMed ID: 19841889
    [No Abstract]   [Full Text] [Related]  

  • 10. Fenofibrate set to benefit from new research on its active metabolite, fenofibric acid.
    Cardiovasc J Afr; 2008; 19(3):171-2. PubMed ID: 18568186
    [No Abstract]   [Full Text] [Related]  

  • 11. A large frontal QRS-T angle is a strong predictor of the long-term risk of myocardial infarction and all-cause mortality in the diabetic population.
    May O; Graversen CB; Johansen MØ; Arildsen H
    J Diabetes Complications; 2017 Mar; 31(3):551-555. PubMed ID: 28065667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular prognosis in patients with type 2 diabetes: contribution of heart and kidney subclinical damage.
    Sosner P; Hulin-Delmotte C; Saulnier PJ; Cabasson S; Gand E; Torremocha F; Piguel X; Miot A; Maréchaud R; Herpin D; Ragot S; Hadjadj S;
    Am Heart J; 2015 Jan; 169(1):108-14.e7. PubMed ID: 25497255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myocardial infarction in patients with diabetes mellitus type 2].
    Ochotny R; Piszczek I; Błaszyk K; Poprawski K
    Kardiol Pol; 1988; 31(9):563-8. PubMed ID: 3244232
    [No Abstract]   [Full Text] [Related]  

  • 14. Reducing the cardiovascular consequences of diabetes mellitus.
    Passa P
    Diabet Med; 1998; 15 Suppl 4():S69-72. PubMed ID: 9868997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors predictive of cardiovascular disease in patients with type-2 diabetes and hypercholesterolemia. ESODIAH study].
    Pintó X; Corbella E; Figueras R; Biarnés J; Ricart W; Morales C; Falkon L; Masana L;
    Rev Esp Cardiol; 2007 Mar; 60(3):251-8. PubMed ID: 17394870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promise, Innovation, Potency, and Efficacy: The PIPE Dream of Sodium-Glucose Co-Transporter 2 Inhibitors.
    Butler J
    Am J Cardiol; 2019 Dec; 124 Suppl 1():S1-S2. PubMed ID: 31741434
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycaemic control and macrovascular complications of type 2 diabetes.
    Dandona P; Chaudhuri A
    Natl Med J India; 2008; 21(6):271-4. PubMed ID: 19691214
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?
    Peter R; Reilly E; Anthony S
    Curr Opin Lipidol; 2010 Dec; 21(6):554-5. PubMed ID: 21206346
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diabetes and hypertension. Results from the ADVANCE study].
    Mehlsen J
    Ugeskr Laeger; 2008 Feb; 170(7):531-2. PubMed ID: 18291082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.